HealthQuill Pharma
The FDA has approved Pfizer’s Besponsa drug for pediatric patients aged one year and above to treat acute leukaemia.
Drugs Health Pharma

Pfizer’s pediatric leukaemia drug gets regulator FDA’s green light

HQ Team March 7, 2024: The FDA has approved Pfizer’s Besponsa drug for pediatric patients aged one year and above to treat acute.

Read More
An 82-year-old German male, who took Covid-19 vaccine 217 times, did not have his immune system weakened but rather strengthened, researchers said.
Drugs Health Pharma

German male injects Covid-19 vaccines 217 times, immunity didn’t weaken

HQ Team March 7, 2024: An 82-year-old German male, who took Covid-19 vaccine 217 times, did not have his immune system weakened but.

Read More
Greenhouse gas emissions will rob the Arctic ice as early as the 2030s in summer, resulting in a significant impact on seals and polar bears, and triggering coastal erosion.
Climate Health Pharma

Arctic may be ice-free for a month by mid-century: UC Boulder researchers

HQ Team March 7, 2024: Greenhouse gas emissions will rob the Arctic ice as early as the 2030s in summer, resulting in a significant impact.

Read More
A chip, developed by the US-based National Institute of Standards and Technology, to convert light into microwaves, can improve the quality of high-precision timing and communication systems, according to a statement.
Climate Medical Pharma

New chip to aid weather scientists, astronomers, cellphone firms

HQ Team March 7, 2024: A chip, developed by the US-based National Institute of Standards and Technology, to convert light into microwaves, can.

Read More
Novo Nordisk’s diabetes drug Ozempic delayed the progression of kidney disease and cardiovascular and kidney death in 24% of people involved in trials, the company announced.
Drugs Health Pharma

Novo Nordisk says Ozempic reduces kidney disease progression 

HQ Team March 6, 2024: Novo Nordisk’s diabetes drug Ozempic delayed the progression of kidney disease and cardiovascular and kidney deaths in 24%.

Read More
The mismatch between what is being portrayed as  “perfect” and “what one has“ leads to a distorted body image. 
Drugs Health Pharma

Opinion: Ignore fitspo, embrace body neutrality to counter dysmorphia

By Aparna S March 5, 2024: “My body is not yours to critique and discuss. My body is not yours for consumption. My.

Read More
US-based Akero Therapeutics, Inc., announced its mid-trial of a drug to treat fatty liver disease met its primary goals of efficacy and safety in patients, according to a company statement.
Drugs Health Pharma

Akero Therapeutics says mid-stage trials on drug for fatty liver disease positive

HQ Team March 4, 2024: US-based Akero Therapeutics, Inc., announced its mid-trial of a drug to treat fatty liver disease met its primary.

Read More
Bayer AG, a German multinational pharmaceutical and biotechnology company, has bought the marketing rights in Europe for a heart drug for $310 million to expand its cardiology portfolio.
Drugs Health Pharma

Bayer acquires marketing rights for heart drug in Europe for $310 million

HQ Team March 4, 2024: Bayer AG, a German multinational pharmaceutical and biotechnology company, has bought the marketing rights in Europe for a.

Read More
A third consecutive year of record low sea ice levels in the Antarctic sea is “shocking” geologists and glaciologists say, even though a rapid loss of ice has been observed since the seventies.
Climate Health Pharma

Divergent scientific views emerge on “shocking” record low ice in Antarctica

HQ Team March 3, 2024: A third consecutive year of record low sea ice levels in the Antarctic sea is “shocking” geologists and.

Read More
Antibodies to target a hard-to-spot region or the “dark side” of the influenza virus were discovered by researchers, and may pave new vaccines and therapies to fight the disease.
Drugs Health Pharma

Antibody discovery may aid new vaccines, therapies to fight influenza

HQ Team March 3, 2024: Antibodies to target a hard-to-spot region or the “dark side” of the influenza virus were discovered by researchers,.

Read More